ArticleAAPS PharmSciTech2022

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line.

Abdelrahman Y Sherif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.